Home > Insider Trading > Filing (0001645113-21-000036)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645113	Novocure Ltd	NVCR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1632237	Ely Benaim	C/O Novocure Inc., 20 Valley Stream Parkway, Suite 300 Malvern PA 19355	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2021-03-03	3,475	$69.37	41,540	No	4	M	Direct
Ordinary Shares	Disposition	2021-03-03	3,475	$150.78	38,065	No	4	S	Direct
Restricted Share Units	Disposition	2021-03-04	1,888	$137.55	36,177	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Options to Buy Ordinary Shares	Disposition	2021-03-03	3,475	$0.00	3,475	$69.37

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,878		2030-03-02	No	4	M	Direct

Footnotes

Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units vested on March 3, 2021. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Fully vested as of the date hereof.